Organization Profile

You just read:

Echo Pharmaceuticals Announces Phase 2 Results for Namisol(R), Its' Pipeline Product for Oral Administration of DELTA9-Tetrahydrocannabinol and Appoints The Sage Group

News provided by

Echo Pharmaceuticals

Jul 11, 2013, 12:05 ET